Literature DB >> 10400703

PTEN interactions with focal adhesion kinase and suppression of the extracellular matrix-dependent phosphatidylinositol 3-kinase/Akt cell survival pathway.

M Tamura1, J Gu, E H Danen, T Takino, S Miyamoto, K M Yamada.   

Abstract

The tumor suppressor PTEN is a phosphatase with sequence homology to tensin. PTEN dephosphorylates phosphatidylinositol 3,4, 5-trisphosphate (PIP3) and focal adhesion kinase (FAK), and it can inhibit cell growth, invasion, migration, and focal adhesions. We investigated molecular interactions of PTEN and FAK in glioblastoma and breast cancer cells lacking PTEN. The PTEN trapping mutant D92A bound wild-type FAK, requiring FAK autophosphorylation site Tyr397. In PTEN-mutated cancer cells, FAK phosphorylation was retained even in suspension after detachment from extracellular matrix, accompanied by enhanced PI 3-K association with FAK and sustained PI 3-K activity, PIP3 levels, and Akt phosphorylation; expression of exogenous PTEN suppressed all five properties. PTEN-mutated cells were resistant to apoptosis in suspension, but most of the cells entered apoptosis after expression of exogenous PTEN or wortmannin treatment. Moreover, overexpression of FAK in PTEN-transfected cells reversed the decreased FAK phosphorylation and PI 3-K activity, and it partially rescued PIP3 levels, Akt phosphorylation, and PTEN-induced apoptosis. Our results show that FAK Tyr397 is important in PTEN interactions with FAK, that PTEN regulates FAK phosphorylation and molecular associations after detachment from matrix, and that PTEN negatively regulates the extracellular matrix-dependent PI 3-K/Akt cell survival pathway in a process that can include FAK.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10400703     DOI: 10.1074/jbc.274.29.20693

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  116 in total

1.  Akt/PKB regulates laminin and collagen IV isotypes of the basement membrane.

Authors:  X Li; U Talts; J F Talts; E Arman; P Ekblom; P Lonai
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-04       Impact factor: 11.205

2.  Cooperative control of Akt phosphorylation, bcl-2 expression, and apoptosis by cytoskeletal microfilaments and microtubules in capillary endothelial cells.

Authors:  D A Flusberg; Y Numaguchi; D E Ingber
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

3.  Hypoxia induces cardiac fibroblast proliferation and phenotypic switch: a role for caveolae and caveolin-1/PTEN mediated pathway.

Authors:  Yao Gao; Ming Chu; Jian Hong; Jingping Shang; Di Xu
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

4.  AKT1E17K Activates Focal Adhesion Kinase and Promotes Melanoma Brain Metastasis.

Authors:  David A Kircher; Kirby A Trombetti; Mark R Silvis; Gennie L Parkman; Grant M Fischer; Stephanie N Angel; Christopher M Stehn; Sean C Strain; Allie H Grossmann; Keith L Duffy; Kenneth M Boucher; Martin McMahon; Michael A Davies; Michelle C Mendoza; Matthew W VanBrocklin; Sheri L Holmen
Journal:  Mol Cancer Res       Date:  2019-05-28       Impact factor: 5.852

5.  PTEN and p16 genes as epigenetic biomarkers in oral squamous cell carcinoma (OSCC): a study on south Indian population.

Authors:  P S Sushma; Kaiser Jamil; P Uday Kumar; U Satyanarayana; M Ramakrishna; B Triveni
Journal:  Tumour Biol       Date:  2015-12-19

Review 6.  Mechanotransduction in skeletal muscle.

Authors:  Thomas J Burkholder
Journal:  Front Biosci       Date:  2007-01-01

7.  CRKL Mediates p110β-Dependent PI3K Signaling in PTEN-Deficient Cancer Cells.

Authors:  Jing Zhang; Xueliang Gao; Fabienne Schmit; Guillaume Adelmant; Michael J Eck; Jarrod A Marto; Jean J Zhao; Thomas M Roberts
Journal:  Cell Rep       Date:  2017-07-18       Impact factor: 9.423

8.  The radiosensitization effect of parthenolide in prostate cancer cells is mediated by nuclear factor-kappaB inhibition and enhanced by the presence of PTEN.

Authors:  Yulan Sun; Daret K St Clair; Fang Fang; Graham W Warren; Vivek M Rangnekar; Peter A Crooks; William H St Clair
Journal:  Mol Cancer Ther       Date:  2007-09       Impact factor: 6.261

9.  Novel HSP90 inhibitor NVP-HSP990 targets cell-cycle regulators to ablate Olig2-positive glioma tumor-initiating cells.

Authors:  Jun Fu; Dimpy Koul; Jun Yao; Shuzhen Wang; Ying Yuan; Howard Colman; Erik P Sulman; Frederick F Lang; W K Alfred Yung
Journal:  Cancer Res       Date:  2013-03-14       Impact factor: 12.701

10.  Expression of focal adhesion kinase and alpha5 and beta1 integrins in carcinomas and its clinical significance.

Authors:  Jian-Min Su; Lu Gui; Yi-Ping Zhou; Xi-Liang Zha
Journal:  World J Gastroenterol       Date:  2002-08       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.